Table 1.
Characteristic | No. (%) |
---|---|
Age, y, median (range) | 61 (45–81) |
Female sex | 7 (58.3) |
BMI, kg/m2, median (range) | 34.0 (27.9–40.6) |
Obesity grade 1 (>30–<35) | 3 (25) |
Obesity grade 2 (>35–<40) | 5 (41.7) |
Obesity grade 3 (>40) | 1 (8.3) |
Underlying joint disorder for arthroplasty | |
Degenerative | 9 (75) |
Trauma | 2 (16.7) |
“Head necrosis” | 1 (8.3) |
Place of last arthroplasty surgery before infection | |
University Hospital of Balgrist | 7 (58.3) |
Other hospital | 5 (41.7) |
Localization of infection | 12 |
Hip PJI | 10 (83.3) |
Shoulder PJI | 2 (16.7) |
Signs and symptoms | |
Pain | 12 (100) |
Wound secretion or sinus tract | 6 (50) |
Swelling, skin erythema | 4 (33.3) |
Fever | 4 (33.3) |
Time to diagnosis of infection after last surgical revision of arthroplastya | |
Median (range), wk | 13.1 (2.3–63.2) |
Time to initial septic surgery after last surgical revision of arthroplasty | |
Median (range), wk | 30.2 (2.9–100.3) |
Surgical treatment | |
DAIR including partial exchange of prosthesis | 5 (41.6) |
1-stage exchange | 2 (16.7) |
2-stage exchange | 4 (33.3) |
Antibiotic treatment only | 1 (8.3) |
Per oral antibiotic treatment after initial IV treatment | |
Clindamycin | 4 (33.3) |
Levofloxacin/rifampin | 4 (33.3) |
Ciprofloxacin/rifampin | 2 (16.7) |
Clindamycin/rifampin | 2 (16.7) |
Abbreviations: BMI, body mass index; DAIR, debridement-antibiotics-irrigation-retention; IV, intravenous; PJI, prosthetic joint infection.
aTime to first microbiological diagnosis of P. avidum (either preoperative synovial puncture or intraoperative tissue samples) with confirmation of infection due to Musculoskeletal Infection Society criteria [13].